The global Viral Vectors for Non-human Primates Market is poised for significant expansion over the next decade, driven by accelerating research in gene therapy, vaccine development, and translational medicine. Valued at US$ 145.8 Mn in 2023, the industry is projected to advance at a robust compound annual growth rate (CAGR) of 10.5% from 2024 to 2034, reaching more than US$ 429.9 Mn by the end...